MARKET

IVVD

IVVD

Invivyd
NASDAQ
0.7834
-0.0203
-2.53%
After Hours: 0.8100 +0.0266 +3.40% 19:25 07/10 EDT
OPEN
0.8150
PREV CLOSE
0.8037
HIGH
0.8150
LOW
0.7676
VOLUME
2.01M
TURNOVER
--
52 WEEK HIGH
3.070
52 WEEK LOW
0.4830
MARKET CAP
230.80M
P/E (TTM)
-2.1932
1D
5D
1M
3M
1Y
5Y
1D
Analysts Conflicted on These Healthcare Names: Cipher Pharmaceuticals (OtherCPHRF), Invivyd (IVVD) and Merck & Company (MRK)
TipRanks · 3d ago
Invivyd: Buy Rating Reiterated as PEMGARDA EUA Transition Seen as Administrative; $10 Price Target Unchanged
TipRanks · 4d ago
Invivyd Price Target Maintained With a $10.00/Share by BTIG
Dow Jones · 5d ago
BTIG Reiterates Buy on Invivyd, Maintains $10 Price Target
Benzinga · 5d ago
FDA to End Emergency Use Authorization For Invivyd's Covid-19 Prevention Shot
Dow Jones · 5d ago
Invivyd gets notice of Pemgarda EUA termination
Seeking Alpha · 6d ago
Invivyd Plans Post-EUA Pathway for PEMGARDA Antibody
TipRanks · 6d ago
Invivyd announces notice of termination for Pemgarda Emergency Use Authorization
TipRanks · 6d ago
More
About IVVD
Invivyd, Inc. is a biopharmaceutical company. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The Company delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2. Its PEMGARDA (pemivibart) is the Company's first mAb to receive regulatory authorization and is designed to keep pace with SARS-CoV-2 viral evolution. PEMGARDA is used for the pre-exposure prophylaxis (prevention) of COVID-19 in adults and adolescents. Its VYD2311 is optimized for neutralization potency against SARS-CoV-2 lineages such as BA.2.86 and JN.1. The Company also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.

Webull offers Invivyd Inc stock information, including NASDAQ: IVVD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IVVD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IVVD stock methods without spending real money on the virtual paper trading platform.